Inventor
YANG DONGLAI
US15 patents
⚠️ This page may combine multiple inventors who share the name “YANG DONGLAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GUSHURST KAREN S
6 patentsUS8569326B2Oct 29, 2013
Forms of rifaximin and uses thereof
GUSHURST KAREN S16 citations91
US8486956B2Jul 16, 2013
Forms of rifaximin and uses thereof
GUSHURST KAREN S13 citations91
US8067429B2Nov 29, 2011
Forms of rifaximin and uses thereof
GUSHURST KAREN S23 citations89
US9181274B2Nov 10, 2015
Forms of rifaximin and uses thereof
GUSHURST KAREN S4 citations82
US8754098B2Jun 17, 2014
Forms of rifaximin and uses thereof
GUSHURST KAREN S5 citations82
US9359357B2Jun 7, 2016
Forms of rifaximin and uses thereof
GUSHURST KAREN S0 citations51
GENZYME CORP
4 patentsUS11110055B2Sep 7, 2021
Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors
GENZYME CORP7 citations82
US10219998B2Mar 5, 2019
Pharmaceutical formulations of tropomyosin related kinase (Trk) inhibitors
GENZYME CORP10 citations82
US11793749B2Oct 24, 2023
Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors
GENZYME CORP3 citations71
US12527737B2Jan 20, 2026
Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors
GENZYME CORP0 citations61